Further Development Activities. (a) The parties will discuss from time to time as necessary allocation of responsibility, including costs, for conducting preclinical development of the Product, including the following tasks: (i) [ * ] (ii) [ * ] (iii) [ * ] (iv) [ * ] (v) [ * ] (vi) [ * ] (b) Sumitomo shall be responsible for conducting or having conducted clinical trials in the Sumitomo Territory.
Appears in 3 contracts
Sources: Collaboration Agreement (Tularik Inc), Collaboration Agreement (Tularik Inc), Collaboration Agreement (Tularik Inc)